New and emerging lipid-modifying drugs to lower LDL cholesterol

New and emerging lipid-modifying drugs to lower LDL cholesterol

Cardiovascular disease (CVD) represents the leading cause of death worldwide. The role of low-density lipoprotein-cholesterol (LDL-C) in the pathophysiology of atherosclerosis and CVD has been well recognized. Statins are the standard of care for the management of hypercholesterolaemia, and their ef...

Full description

Saved in:
Bibliographic Details
Main Authors: Constantine E Kosmas (Author), Dafni Pantou (Author), Andreas Sourlas (Author), Evangelia J Papakonstantinou (Author), Rogers Echavarria Uceta (Author), Eliscer Guzman (Author)
Format: Book
Published: BioExcel Publishing Ltd, 2021-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items